Perflutren Lipid Microspheres and Ranibizumab Intraocular
Determining the interaction of Perflutren Lipid Microspheres and Ranibizumab Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: perflutren
Brand name: Definity, Optison
Synonyms: Perflutren
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Perflutren Lipid Microspheres-Ranibizumab ophthalmic
- Perflutren Lipid Microspheres-Ranitidine
- Perflutren Lipid Microspheres-Ranitidine Capsule
- Perflutren Lipid Microspheres-Ranitidine Hydrochloride
- Perflutren Lipid Microspheres-Ranitidine Injection
- Perflutren Lipid Microspheres-Ranitidine Suspension
- Ranibizumab Intraocular-Perflutren Protein Type A
- Ranibizumab Intraocular-Perflutren protein type a microsphere Intravenous
- Ranibizumab Intraocular-Perforomist
- Ranibizumab Intraocular-Perforomist, Symbicort
- Ranibizumab Intraocular-Pergolide
- Ranibizumab Intraocular-Pergonal